Jazz Pharmaceuticals (JAZZ) PT Raised at TD Cowen Following 'Nice Topline Beat And Raise' Aug 4, 2026 09:16AM
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences May 12, 2026 04:15PM
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences Feb 17, 2026 04:15PM
TD Cowen Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ) Apr 22, 2025 09:34AM
Jazz Pharmaceuticals to Participate in TD Cowen's 45th Annual Health Care Conference Feb 20, 2025 04:15PM


Jan 6, 2025 10:35AM TD Cowen: '10 Potential "Thome Run" Catalysts to Watch in 2025'
Dec 17, 2024 10:08AM TD Cowen Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ) Following CEO Transition Plan Announcement
Nov 21, 2024 07:46AM TD Cowen Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
Aug 28, 2024 02:57PM TD Cowen Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
Aug 23, 2024 07:53AM TD Cowen Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
May 29, 2024 02:21PM TD Cowen Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
May 2, 2024 02:00PM Jazz Pharmaceuticals (JAZZ) PT Lowered to $200 at TD Cowen
Feb 20, 2024 04:15PM Jazz Pharmaceuticals to Participate in Upcoming March Investor Conferences
Sep 13, 2023 04:15PM Jazz Pharmaceuticals to Participate in Three Upcoming Investor Conferences
Feb 27, 2023 04:15PM Jazz Pharmaceuticals to Participate in Upcoming March Investor Conferences
Feb 28, 2022 04:15PM Jazz Pharmaceuticals to Participate in Upcoming March Investor Conferences
May 10, 2021 11:45AM Jazz Pharmaceuticals (JAZZ) Expanded Access Program Suggests JZP-458 Launch is On Track - Cowen
Apr 20, 2021 12:08PM Cowen's Conviction on Jazz Pharmaceuticals (JAZZ) 'Growing Stronger', Buy on Weakness
Feb 23, 2021 04:10PM Jazz Pharmaceuticals Announces Participation at Cowen 41st Annual Healthcare Conference
Feb 3, 2021 12:02PM Jazz Pharmaceuticals (JAZZ) PT Raised to $190 at Cowen, Positive on GW Deal
Feb 26, 2020 04:05PM Jazz Pharmaceuticals Announces Participation at Upcoming Investor Conferences
Mar 5, 2019 04:05PM Jazz Pharmaceuticals to Present at the Cowen and Company 39th Annual Healthcare Conference
Nov 7, 2018 08:57AM Jazz Pharmaceuticals (JAZZ) PT Lowered to $200 at Cowen
Jul 13, 2018 10:57AM Buy Jazz Pharmaceuticals (JAZZ) 'Aggressively' on Xyrem Headline Weakness - Cowen
Jun 27, 2018 06:21AM Jazz Pharmaceuticals (JAZZ) PT Raised to $220 at Cowen; 'Transitioning Growth Asset'
Apr 16, 2018 08:40AM Cowen Reviews Eight Potential Strategic Options Allergen (AGN); PT Lowered to $255
Mar 6, 2018 04:05PM Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March
Aug 8, 2017 07:20AM Jazz Pharmaceuticals (JAZZ): KOLs Highlight Vyxeos Opportunity - Cowen
Jun 7, 2017 05:58AM Jazz Pharmaceuticals' (JAZZ) JZP-110 Seen as $750M+ Product - Cowen
May 10, 2017 08:19AM Jazz Pharmaceuticals (JAZZ): Upside Is Clear - Cowen
Apr 6, 2017 06:26AM Jazz Pharmaceuticals (JAZZ): Xyrem Terms Are Very Favorable - Cowen
Mar 20, 2017 11:33AM Cowen Reiterates Outperform Rating and $190 PT on Jazz Pharmaceuticals (JAZZ) Following Positive JZP-110 Data; 'A Complete Re-Rating is Nearing'
Mar 1, 2017 04:05PM Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March
Mar 2, 2016 04:05PM Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March
Apr 27, 2015 03:39PM Teva (TEVA) Likely to Offer $90/Share for Mylan (MYL) in Next Step, Cowen Says
Sep 11, 2012 10:37AM Notable Analyst Rating Changes 09/11: (BMY) (SYNC) (JAZZ) Upgraded; (SIRI) (TIBX) (GNOM) Downgraded
Sep 11, 2012 09:51AM Cowen Upgrades Jazz Pharmaceuticals (JAZZ) to Outperform
Sep 6, 2012 09:05AM Cowen Starts Jazz Pharmaceuticals (JAZZ) at Neutral
Apr 13, 2012 11:06AM Notable Analyst Rating Changes 04/13: (JCI) (RRC) (DOV) Upgraded; (ITW) (CNX) (NOK) Downgraded